Ftse Mib
34.561,65
0,83%
DAX
18.521,38
0,56%
S&P 500
5.291,34
0,15%
NASDAQ
16.857,05
0,17%
Bitcoin
70.865,44
0,34%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aura Biosciences Inc (AURA) Aura Biosciences Inc (AURA) Notizie

Aura Biosciences Inc

AURA
7,19
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:26:11
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/6/202423:07EDGAR2Form 8-K - Current report
30/5/202422:05GLOBEAura Biosciences to Participate in the Jefferies Global..
23/5/202414:00GLOBEAura Biosciences to Host Virtual KOL Event “Pioneering a New..
09/5/202413:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:05EDGAR2Form 8-K - Current report
09/5/202413:00GLOBEAura Biosciences Reports First Quarter 2024 Financial..
08/5/202413:00GLOBEAura Biosciences to Participate in Upcoming Investor..
27/3/202412:00BWAura Biosciences Reports Fourth Quarter and Full Year 2023..
04/3/202423:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202413:00BWAura Biosciences to Participate in Upcoming Investor..
23/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
02/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:01EDGAR2Form 144 - Report of proposed sale of securities
08/1/202422:11EDGAR2Form 144 - Report of proposed sale of securities
08/1/202413:31EDGAR2Form 8-K - Current report
02/1/202422:29EDGAR2Form 144 - Report of proposed sale of securities
15/12/202322:30EDGAR2Form 144 - Report of proposed sale of securities
07/12/202314:00BWAura Biosciences Announces First Patient Dosed in Global..
09/11/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:15EDGAR2Form 8-K - Current report
09/11/202322:05BWAura Biosciences Reports Third Quarter 2023 Financial..
08/11/202313:00BWAura Biosciences to Participate in Upcoming Investor..
08/11/202300:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202300:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/11/202304:02BWAura Biosciences Announces Pricing of Public Offering of..
06/11/202322:22EDGAR2Form 144 - Report of proposed sale of securities
06/11/202322:20EDGAR2Form 144 - Report of proposed sale of securities
06/11/202322:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/11/202322:08BWAura Biosciences Announces Proposed Public Offering of..
06/11/202322:01EDGAR2Form 8-K - Current report
06/11/202321:50DJNAura Biosciences Gets FDA Agreement Regarding Phase 3..
06/11/202321:00BWAura Biosciences Receives FDA Agreement Under Special..
03/11/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:16EDGAR2Form 144 - Report of proposed sale of securities
03/11/202321:15EDGAR2Form 144 - Report of proposed sale of securities
03/11/202321:15EDGAR2Form 144 - Report of proposed sale of securities
01/11/202323:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202321:05BWAura Biosciences to Present Updated Phase 2 Data Evaluating..
24/10/202302:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/10/202301:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:11EDGAR2Form 8-K - Current report
02/10/202322:05BWAura Biosciences Strengthens and Expands Leadership Team..
09/8/202313:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202313:05EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 7,19

La tua Cronologia

NASDAQ
AURA
Aura Biosciences
NASDAQI
OMXC25NI
OMX Copenhagen 25 NI
BIT
UB1C4C
Unicredit Bank
ASX
APPDA
LSE
52LL
Sthn.pac.42a1ba
USOTC
KUYAF
Kuya Silver (QB)
GDAX
MANAETH
Decentraland
ASX
A40
Alita Resources
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network